StockWatch
·

Sundaram-Clayton Ltd Q2 FY27 Results

SUNCLAYQ2 FY27 Results
Filing
Result:Weak· Market: Up#Margin squeeze#Cost led
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue697.7217.9%41.0%
Total Income699.9717.6%40.4%
Expenditure737.0913.6%32.2%
PBT-37.1230.3%37.1%
Net Profit-50.7714.4%21.1%
OPM4.64%2.63pp1.64pp
NPM-7.25%2.72pp5.66pp
EPS-23.03185.6%178.9%
View full financials

Consolidated remains a net loss (₹50.8 Cr) despite 41% revenue growth and a narrowing deficit, with standalone EBITDA margin contracting to 15.7% from 17.1% on alloy/energy/logistics cost pressure and the US unit still posting a ₹90.5 Cr loss.

Q2 FY-2027 RESULTS · SUNCLAY

Consolidated loss narrows to ₹50.8 Cr; standalone PAT jumps 96% as US drag persists

PAT +21.1% YoY · revenue +41.03% · margins expanding

04 Nov 2026 · 3 min read
Revenue

₹697.72 Cr

+41.03% YoY

PAT (consolidated)

₹-50.77 Cr

+21.1% YoY

Net margin

-7.25%

+5.7pp YoY

EPS

₹-23.03

Sundaram-Clayton's consolidated net loss narrowed to ₹50.8 Cr in Q2 FY27 from ₹64.4 Cr a year ago and ₹59.3 Cr last quarter, as revenue grew 41% YoY (18% QoQ) to ₹697.7 Cr. On a standalone basis — which excludes the loss-making US operations — the print was far stronger: revenue grew 37% YoY to ₹629.4 Cr and PAT nearly doubled to ₹39.5 Cr from ₹20.2 Cr, taking EPS to ₹17.91 from ₹9.16. The divergence is the story: India operations are solidly profitable and accelerating, while the US subsidiary continues to post losses large enough to pull the consolidated book into the red.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹697.72 Cr+17.9%+41%
Expenses₹737.09 Cr+13.6%+32.2%
PAT₹-50.77 Cr+14.43%+21.1%
Net margin-7.25%+2.7pp+5.7pp
EPS₹-23.03-185.6%-178.9%

Consolidated NPM improved to -7.3% from -12.9% a year ago and -10.0% last quarter, confirming the loss is narrowing on an operating basis and not just at the net line. On the standalone book, management's own numbers show EBITDA of ₹98.9 Cr at a 15.7% margin, up from ₹79.1 Cr in absolute terms but down from a 17.1% margin a year ago — alloy, energy and logistics cost pressure diluted the margin even as volumes and PAT grew; the bottom line was helped by lower finance costs (₹16.6 Cr vs ₹19.9 Cr) even as the effective tax rate rose. Per the auditor's review note, the unreviewed US entities alone carried a net loss of ₹90.5 Cr on revenue of ₹83.1 Cr for the quarter, underscoring that the US business remains the primary drag on the consolidated result even as "production at the US facility continued to ramp up," per the company.

₹
985.871,074.041,162.21,250.361,338.531,181.508-0308-2509-1710-1211-04Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹1,181.5, up 0.8% over the past month of trading.

₹ Cr
-123.2479.61282.45485.3-57.76Q1 FY26rev ₹512 Cr-64.35Q2 FY26rev ₹495 Cr-51.92Q3 FY26rev ₹501 Cr426.41Q4 FY26rev ₹518 Cr-59.33Q1 FY27rev ₹592 Cr-50.77Q2 FY27rev ₹698 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.

No prior management guidance or concall commentary is on record for this quarter, and no sell-side consensus estimates for Q2 FY27 could be located, so vsGuidance and vsStreet are both unknown. There were no exceptional items in either the current or year-ago quarter (unlike Q4 FY26, which carried a ₹521.2 Cr asset-sale gain), so the YoY comparison is clean. Demand tailwinds cited by management include M&HCV volumes up 23% YoY in H1 (33% in Q2, aided by pre-buying ahead of an October price hike) and passenger-vehicle volumes up 24% YoY on GST 2.0-aided affordability; in the US, Class 8 retail sales rose 10% YoY in Q3 CY2026 with production up 53%, which management frames as an improving backdrop for the ramping US facility. Separately, the board approved raising up to ₹700 Cr via NCDs/other borrowings, a balance-sheet action concurrent with the results but not yet reflected in this quarter's numbers.

  • W1

    Pace of US loss-narrowing — unreviewed US entities lost ₹90.5 Cr this quarter; watch whether restructuring narrows this further next quarter

  • W2

    Standalone EBITDA margin trajectory — fell to 15.7% from 17.1% YoY on input costs; watch if alloy/energy/logistics pressure eases

  • W3

    Use of the ₹700 Cr NCD/borrowing approval — watch for actual issuance size and stated purpose (capex vs refinancing)

Informational and educational content only. Not investment advice.